Literature DB >> 11786396

Characterization of prostate cell types by CD cell surface molecules.

Alvin Y Liu1, Lawrence D True.   

Abstract

A set of monoclonal antibodies raised against lymphocyte cell surface molecules, the cluster designation (CD) antigens, was used to distinguish the constituent cell types of the prostate. The luminal secretory epithelial, basal epithelial, fibromuscular stromal, nerve sheath, and endothelial cells express distinctive complements of cell surface molecules that were identified by immunohistochemistry using 152 commercially available antibodies. Many of the CD antibodies stained lymphocyte populations in the prostate. These lymphocyte populations were grouped into abundance classes of rare, moderate, and high. Some of these molecules are expressed by multiple cell types, both parenchymal and lymphoid; others are expressed by only one cell type. Distinctive patterns of CD expression, which are most similar to the expression pattern of prostate luminal cells, also characterize a small series of Gleason score 6 prostate cancers. The cell-type specificity of CD molecules increases the prospect of isolating specific cell populations, using such techniques as laser capture microdissection and flow cytometry, for cell-specific molecular studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786396      PMCID: PMC1867111          DOI: 10.1016/S0002-9440(10)64346-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Differential expression of the lysosome-associated membrane proteins in normal human tissues.

Authors:  K Furuta; X L Yang; J S Chen; S R Hamilton; J T August
Journal:  Arch Biochem Biophys       Date:  1999-05-01       Impact factor: 4.013

2.  Changes in cell surface molecules associated with in vitro culture of prostatic stromal cells.

Authors:  A Y Liu; L LaTray; G van Den Engh
Journal:  Prostate       Date:  2000-09-01       Impact factor: 4.104

3.  Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.

Authors:  G Theyer; G Kramer; I Assmann; E Sherwood; W Preinfalk; M Marberger; O Zechner; G E Steiner
Journal:  Lab Invest       Date:  1992-01       Impact factor: 5.662

4.  Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.

Authors:  R E Reiter; Z Gu; T Watabe; G Thomas; K Szigeti; E Davis; M Wahl; S Nisitani; J Yamashiro; M M Le Beau; M Loda; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

5.  Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.

Authors:  S Shimura; G Yang; S Ebara; T M Wheeler; A Frolov; T C Thompson
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

6.  Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue.

Authors:  T Bogenrieder; C L Finstad; R H Freeman; C N Papandreou; H I Scher; A P Albino; V E Reuter; D M Nanus
Journal:  Prostate       Date:  1997-12-01       Impact factor: 4.104

7.  Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression.

Authors:  C N Papandreou; B Usmani; Y Geng; T Bogenrieder; R Freeman; S Wilk; C L Finstad; V E Reuter; C T Powell; D Scheinberg; C Magill; H I Scher; A P Albino; D M Nanus
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

8.  Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands.

Authors:  M J Wilson; A R Ruhland; B J Quast; P K Reddy; S L Ewing; A A Sinha
Journal:  J Androl       Date:  2000 Mar-Apr

9.  Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis.

Authors:  K L Simpson; C H Holmes
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

10.  Sialyl-Lewis(x) and related carbohydrate antigens in the prostate.

Authors:  S Mårtensson; S A Bigler; M Brown; P H Lange; M K Brawer; S Hakomori
Journal:  Hum Pathol       Date:  1995-07       Impact factor: 3.466

View more
  31 in total

1.  Isolation and functional characterization of murine prostate stem cells.

Authors:  Devon A Lawson; Li Xin; Rita U Lukacs; Donghui Cheng; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-21       Impact factor: 11.205

2.  Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE).

Authors:  Eric W Deutsch; Catherine A Ball; Jules J Berman; G Steven Bova; Alvis Brazma; Roger E Bumgarner; David Campbell; Helen C Causton; Jeffrey H Christiansen; Fabrice Daian; Delphine Dauga; Duncan R Davidson; Gregory Gimenez; Young Ah Goo; Sean Grimmond; Thorsten Henrich; Bernhard G Herrmann; Michael H Johnson; Martin Korb; Jason C Mills; Asa J Oudes; Helen E Parkinson; Laura E Pascal; Nicolas Pollet; John Quackenbush; Mirana Ramialison; Martin Ringwald; David Salgado; Susanna-Assunta Sansone; Gavin Sherlock; Christian J Stoeckert; Jason Swedlow; Ronald C Taylor; Laura Walashek; Anthony Warford; David G Wilkinson; Yi Zhou; Leonard I Zon; Alvin Y Liu; Lawrence D True
Journal:  Nat Biotechnol       Date:  2008-03       Impact factor: 54.908

3.  Targeting monoamine oxidase A in advanced prostate cancer.

Authors:  Vincent Flamand; Hongjuan Zhao; Donna M Peehl
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-04       Impact factor: 4.553

4.  Bladder expression of CD cell surface antigens and cell-type-specific transcriptomes.

Authors:  Alvin Y Liu; Ricardo Z N Vêncio; Laura S Page; Melissa E Ho; Michelle A Loprieno; Lawrence D True
Journal:  Cell Tissue Res       Date:  2012-03-20       Impact factor: 5.249

5.  Cell surface antigen profiling using a novel type of antibody array immobilised to plasma ion-implanted polycarbonate.

Authors:  Heather Main; Jelena Radenkovic; Elena Kosobrodova; David McKenzie; Marcela Bilek; Urban Lendahl
Journal:  Cell Mol Life Sci       Date:  2014-03-13       Impact factor: 9.261

Review 6.  Reprogramming of prostate cancer cells--technical challenges.

Authors:  Gisely T Borges; Eneida F Vêncio; Ricardo Z N Vêncio; Robert L Vessella; Carol B Ware; Alvin Y Liu
Journal:  Curr Urol Rep       Date:  2015-01       Impact factor: 3.092

Review 7.  Tumour biological aspects of CD24, a mucin-like adhesion molecule.

Authors:  G Kristiansen; M Sammar; P Altevogt
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

8.  Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells involves potential organ-specific genes.

Authors:  Laura E Pascal; Young Ah Goo; Ricardo Zn Vêncio; Laura S Page; Amber A Chambers; Emily S Liebeskind; Thomas K Takayama; Lawrence D True; Alvin Y Liu
Journal:  BMC Cancer       Date:  2009-09-08       Impact factor: 4.430

9.  Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes.

Authors:  Laura E Pascal; Ricardo Z N Vêncio; Laura S Page; Emily S Liebeskind; Christina P Shadle; Pamela Troisch; Bruz Marzolf; Lawrence D True; Leroy E Hood; Alvin Y Liu
Journal:  BMC Cancer       Date:  2009-12-18       Impact factor: 4.430

10.  Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells.

Authors:  Hongjuan Zhao; Vincent Flamand; Donna M Peehl
Journal:  BMC Med Genomics       Date:  2009-08-20       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.